Bitcoin broke above $125,000 for the first time, extending a powerful 2025 rally driven by robust spot ETF demand and improving risk appetite. The milestone lifts crypto-linked equities and puts a spotlight on liquidity, leverage, and potential regulatory responses as volumes swell into Q4.
Source: SeekingAlpha All
Policy jolt: Pfizer–TrumpRx deal sparks record rally across Big Pharma
Pharma stocks staged a record advance after reports of a pricing deal between Pfizer and the Trump administration, easing investor fears of harsher near-term reimbursement pressure. The move resets sentiment ahead of earnings season, though the sector still faces longer-term scrutiny on costs and access.
Source: SeekingAlpha All
HHS escalates drug pricing push with another rule sent for review
The U.S. Department of Health and Human Services advanced a fresh proposed rule on drug pricing for federal review, signaling continued regulatory pressure on the life sciences supply chain. Investors should watch for details on negotiation scope and implementation timelines, which could reshape manufacturer, PBM, and insurer economics.
Source: SeekingAlpha All
Saudi strategy cools oil prices, easing inflation and shifting election calculus
Saudi Arabia’s recent oil-market tactics have helped push prices lower, alleviating consumer inflation and potentially aiding President Trump politically, according to the WSJ. Cheaper crude supports real incomes and risk assets, but it also pressures energy producers’ cash flows and capex plans going into 2026.
Source: SeekingAlpha All
Debt showdowns move center stage for global markets
Investors are refocusing on political risk as debt and budget standoffs at home and abroad threaten to inject volatility into rates, currencies, and equities. With deadlines looming, positioning around the dollar, duration, and defensives may drive near-term performance dispersion.
Source: SeekingAlpha All
Goldman: Q3 S&P 500 growth will slow, but beats still likely
Goldman Sachs expects aggregate S&P 500 earnings growth to cool in Q3 but still come in ahead of consensus, continuing 2025’s pattern of modest beats. Guidance tone and margin resilience will be the key stock-level drivers as investors parse how much of the AI and productivity tailwind is already priced in.
Source: SeekingAlpha All
OpenAI readies Sora monetization, expands controls for rights holders
OpenAI plans to commercialize its generative video model Sora while giving content owners more control, a sign the AI leader is courting revenue growth without inflaming IP risk. The move could accelerate adoption in advertising and entertainment while testing the economics of compute-intensive AI at scale.
Source: SeekingAlpha All
You May Also Be Interested In...
- Spot crypto ETFs outperform trusts and strategy funds
- Bitcoin ETFs log second-biggest weekly inflows ever as “Uptober” kicks off
- Commodities advance in September as precious and industrial metals rally
- Stellantis lines up $10B U.S. investment amid shift back to core market
- Small-cap earnings recovery builds; valuations still compelling: BofA
- California grants ride-share drivers the right to unionize
- Cerebras shelves IPO after raising $1.1B privately
- Novo to offer Wegovy and Ozempic to Costco members at half price